RareCyte
RareCyte is an organization mentioned in articles about Seattle startup funding, specifically noted in coverage of a $24M raise to...
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Healthcare, Life Sciences
- Total raised
- $79.8M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $13.2M · Jul 2023 SEC Form D
Recent coverage
Front-page news, podcasts and videos about RareCyte
RareCyte raises $24M to commercialize Orion 21-channel high-speed cell imaging platform
Seattle startup RareCyte raised $24 million to commercialize and expand its Orion high-speed, 21-channel fluorescent cell imaging and analysis platform and other automated biopsy products for researchers and biopharma.
